TELADOC HEALTH, INC.: diluted earnings per share

What this measure means

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Exact concept: us-gaap:EarningsPerShareDiluted. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2019-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Reading these values

This selected numerical history matches Basic earnings per share for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.

Context from the filing

For 2023–2025, Teladoc uses net loss rather than comprehensive loss as its EPS numerator. Potential common shares, including stock options and convertible notes, are excluded as anti-dilutive. The filing’s outstanding award counts are not additional weighted-average shares to add to the denominator. Shares and per-share data are exempt from the thousands heading and use scale-zero tags; basic and diluted counts should not be added together. Read the source filing.

Selected filing history

Related financial histories

• TELADOC HEALTH, INC.: total assets
• TELADOC HEALTH, INC.: total liabilities
• TELADOC HEALTH, INC.: stockholders equity
• TELADOC HEALTH, INC.: cash and cash equivalents
• TELADOC HEALTH, INC.: net income or loss
• TELADOC HEALTH, INC.: operating cash flow
• TELADOC HEALTH, INC.: capital expenditure payments
• TELADOC HEALTH, INC.: revenue
• TELADOC HEALTH, INC.: contract revenue excluding tax
• TELADOC HEALTH, INC.: financing cash flow
• TELADOC HEALTH, INC.: investing cash flow
• TELADOC HEALTH, INC.: retained earnings or deficit
• TELADOC HEALTH, INC.: basic weighted-average shares
• TELADOC HEALTH, INC.: diluted weighted-average shares
• TELADOC HEALTH, INC.: basic earnings per share
• TELADOC HEALTH, INC.: income tax expense or benefit
• TELADOC HEALTH, INC.: net property, plant and equipment
• TELADOC HEALTH, INC.: share-based compensation expense
• TELADOC HEALTH, INC.: operating income or loss
• TELADOC HEALTH, INC.: current assets
• TELADOC HEALTH, INC.: interest expense
• TELADOC HEALTH, INC.: current liabilities
• TELADOC HEALTH, INC.: current accounts payable
• TELADOC HEALTH, INC.: goodwill carrying amount
• TELADOC HEALTH, INC.: net finite-lived intangible assets
• TELADOC HEALTH, INC.: net current accounts receivable
• TELADOC HEALTH, INC.: net inventory
• TELADOC HEALTH, INC.: gross profit
• TELADOC HEALTH, INC.: cost of revenue
• TELADOC HEALTH, INC.: research and development expense

Inspect the source

Entity

TELADOC HEALTH, INC. / CIK 0001477449

Captured

2026-09-20T09:08:27.891Z

SEC response SHA-256

998019a803d0d7d50679f859e4228a55ab3953cba8d7d0d38070f01b56613faf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001477449.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))